SG
Sridhar Ganesan
About Sridhar Ganesan
Data last updated:
Sridhar Ganesan has 12 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Caplin Point Laboratories Limited and Caplin One Labs Limited. Formerly with 1 company, such as Lagap Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹2,450 Cr; the largest is Caplin Point Laboratories Limited at ₹2,034 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Caplin Point Laboratories Limited L24231TN1990PLC019053 | Managing Director | 12 Feb 2014 | 1990 | ₹2,034 Cr (FY 2025) | Active |
 Caplin Steriles Limited U24304TN2018PLC126270 | Whole-Time Director | 13 Jun 2022 | 2018 | ₹377 Cr (FY 2025) | Active |
 Caplin One Labs Limited U24299TN2021PLC143869 | Director | 02 Jun 2021 | 2021 | ₹38.72 Cr (FY 2025) | Active |
| Argus Salud Pharma Llp AAA-1115 | Designated Partner | 12 Jul 2022 | 2010 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Lagap Pharmaceuticals Private Limited U52399TN2014PTC096156 | Director | 13 Jun 2014 | 2014 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sridhar Ganesan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sridhar Ganesan
Sridhar Ganesan has 12 years in corporate governance. Holds Managing Director and Director roles. Currently with 4 companies, including Caplin Point Laboratories Limited and Caplin One Labs Limited. Formerly with 1 company, such as Lagap Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹2,450 Cr; the largest is Caplin Point Laboratories Limited at ₹2,034 Cr (FY 2025).
Sridhar Ganesan is associated with 4 companies as Managing Director and Director, including Caplin Point Laboratories Limited (₹2,034 Cr), Caplin Steriles Limited (₹377 Cr), Caplin One Labs Limited (₹38.72 Cr).
Sridhar Ganesan has expertise in General Business.
Sridhar Ganesan has 12 years in corporate governance.
By reported revenue, the largest current company of Sridhar Ganesan is Caplin Point Laboratories Limited, with revenue of ₹2,034 Cr (FY 2025).
The 3 current companies of Sridhar Ganesan that report revenue have a combined latest revenue of ₹2,450 Cr.
Sridhar Ganesan currently holds positions at 4 companies: Caplin Point Laboratories Limited (₹2,034 Cr), Caplin Steriles Limited (₹377 Cr), Caplin One Labs Limited (₹38.72 Cr), Argus Salud Pharma Llp.